Adis Journals
Browse

Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

Download (101.55 kB)
figure
posted on 2020-03-31, 10:00 authored by Ken Yoshikawa, Akira Tsuchiya, Tomoyuki Kido, Tomohiro Ota, Keiko Ikeda, Mika Iwakura, Yoshikazu Maeda, Shinichiroh Maekawa
<p></p><p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC. 2020.<b> </b></p><br><p></p>

History

Related Materials

  1. 1.
    URL - References https://link.springer.com/article/10.1007/s12325-020-01293-2
  2. 2.
    DOI - Is supplement to Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    EfficacyObservational studyPost-marketing surveillanceSafetySitagliptinType 2 diabetes mellitus

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC